Unicycive Therapeutics, Inc.
UNCY- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001766140
No open-market purchases or sales by Unicycive Therapeutics, Inc. insiders were filed in the last 90 days; 79 institutions reported holding it in 13F filings for Q2 2026, worth $54.6M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Unicycive Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- +6 vs. Q3 2025
- Shares held
- 8.23M
- +1.97M (+31.5%) vs. Q3 2025
- Total value
- $47.5M
- +$20.2M (+74.1%) vs. Q3 2025
- New holders
- 8
- 8 more added
- Sold out
- 2
- 6 more reduced
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting UNCY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 79 | $54.6M |
| Q1 2026 | 51 | $65.2M |
| Q4 2025 | 35 | $47.5M |
| Q3 2025 | 30 | $27.4M |
| Q2 2025 | 20 | $24.6M |
| Q1 2025 | 29 | $34.5M |
| Q4 2024 | 31 | $49.0M |
| Q3 2024 | 29 | $19.1M |
| Q2 2024 | 24 | $9.52M |
| Q1 2024 | 23 | $31.6M |
| Q4 2023 | 16 | $11.3M |
| Q3 2023 | 16 | $12.2M |
| Q2 2023 | 15 | $1.38M |
| Q1 2023 | 13 | $3.54M |
| Q4 2022 | 9 | $428.3K |
| Q3 2022 | 12 | $571.0K |
| Q2 2022 | 15 | $992.0K |
| Q1 2022 | 12 | $1.48M |
| Q4 2021 | 12 | $2.30M |
| Q3 2021 | 10 | $3.02M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Unicycive Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vivo Capital, LLC | 1,789,916 | $10.3M | 0.67% | 00.0% | Unchanged |
| Millennium Management LLC | 1,014,843 | $5.86M | 0.00% | +1,014,843 | New |
| Octagon Capital Advisors LP | 1,000,000 | $5.77M | 0.72% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 939,202 | $5.42M | 0.32% | 00.0% | Unchanged |
| Great Point Partners LLC | 796,558 | $4.60M | 1.49% | 00.0% | Unchanged |
| Vanguard Group Inc | 788,587 | $4.55M | 0.00% | +129,709+19.7% | Added |
| Logos Global Management LP | 473,563 | $2.73M | 0.18% | 00.0% | Unchanged |
| Citadel Advisors LLC | 258,301 | $1.49M | 0.00% | +216,627+519.8% | Added |
| Cantor Fitzgerald, L. P. | 200,000 | $1.15M | 0.03% | +200,000 | New |
| Geode Capital Management, LLC | 171,290 | $989.2K | 0.00% | +45,563+36.2% | Added |
| BNP Paribas Arbitrage, SA | 99,742 | $575.5K | 0.00% | +99,687+181,249.1% | Added |
| Pavaki Capital Management LLC | 90,000 | $519.3K | 0.36% | +90,000 | New |
| Dauntless Investment Group, LLC | 89,415 | $515.9K | 1.90% | +89,415 | New |
| Omers Administration Corp | 78,200 | $451.2K | 0.00% | +78,200 | New |
| State Street Corp | 65,227 | $376.4K | 0.00% | +10,400+19.0% | Added |
| Acuta Capital Partners, LLC | 59,985 | $346.1K | 0.23% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 55,305 | $319.1K | 0.00% | −62,022−52.9% | Reduced |
| Morgan Stanley | 46,584 | $268.8K | 0.00% | +35,972+339.0% | Added |
| Quadrature Capital Ltd | 39,114 | $225.7K | 0.00% | +39,114 | New |
| BlackRock, Inc. | 36,355 | $209.8K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 35,937 | $207.4K | 0.00% | +3,238+9.9% | Added |
| XTX Topco Ltd | 35,405 | $204.3K | 0.01% | −2,418−6.4% | Reduced |
| Chicago Partners Investment Group LLC | 22,413 | $155.1K | 0.00% | −4,548−16.9% | Reduced |
| Susquehanna International Group, LLP | 24,931 | $143.9K | 0.00% | +24,931 | New |
| UBS Group AG | 19,905 | $114.9K | 0.00% | +14,460+265.6% | Added |
| Tower Research Capital LLC (TRC) | 1,920 | $11.1K | 0.00% | +1,920 | New |
| SBI Securities Co., Ltd. | 558 | $3.22K | 0.00% | −2−0.4% | Reduced |
| Rockefeller Capital Management L.P. | 500 | $2.88K | 0.00% | 00.0% | Unchanged |
| TFC Financial Management | 300 | $1.73K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 228 | $1.32K | 0.00% | −6,464−96.6% | Reduced |
| Bank of America Corp | 152 | $877 | 0.00% | −675−81.6% | Reduced |
| Harbour Investments, Inc. | 100 | $577 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 80 | $462 | 0.00% | 00.0% | Unchanged |
| Bogart Wealth, LLC | 6 | $35 | 0.00% | 00.0% | Unchanged |
| Danske Bank A/S | 1 | $6 | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −45,200−100.0% | Sold out |
| Fortitude Family Office, LLC | 0 | $0 | 0.00% | −107−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | – | – | – | – | Not filed |